At the Liver Meeting, there was positive news about Rezdiffra for MASH and Vir's Hep delta candidate, along with hope on ...
Achieving sustained virological response after direct-acting antiviral therapy reduces liver-related events among those with decompensated HCV cirrhosis.
After over 10 months of being on a liver transplant waitlist, a Kelowna mother is set to get her much needed surgery in early ...
A local Conservative MLA is calling on BC Transplant and the NDP government to immediately intervene in the case of a Kelowna ...
Kelowna mother Lyndsay Richholt was told in March that she has approximately six months to live, her fate now resting on ...
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated diseases, today announced ...
GlobalData on MSN
Aldeyra reshuffles pipeline, culling asset despite Phase II success
Despite ADX-629 meeting all its endpoints in a Phase II trial, Aldeyra is culling the asset as part of a pipeline reprioritisation.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback